Breaking
🌏 NMPA
NMPA Expedited Approval Oncology: Impact on Cancer Drug Access in China
AnalysisOncologyApr 14, 2026

NMPA Expedited Approval Oncology: Impact on Cancer Drug Access in China

The NMPA's expedited approval process is transforming cancer drug access in China, significantly impacting treatments like osimertinib for lung cancer patients.

Dr. Yuki Tanaka